May 2, 2018 / 10:41 AM / in 6 months

BRIEF-Achillion Reports Q1 Loss Per Share $0.15

May 2 (Reuters) - Achillion Pharmaceuticals Inc:

* ACHILLION REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND MANAGEMENT TRANSITION

* Q1 LOSS PER SHARE $0.15

* Q1 EARNINGS PER SHARE VIEW $-0.14 — THOMSON REUTERS I/B/E/S

* MILIND DESHPANDE WILL BE STEPPING DOWN

* PLANS FOR CLINICAL DATA IN C3 GLOMERULOPATHY AND FOR PAROXYSMAL NOCTURNAL HEMOGLOBINURIA REMAIN ON TRACK FOR 2018

* ACHILLION - $1.8 MILLION CHARGES IN QUARTER CONSIST OF EMPLOYEE SEVERANCE PAYMENTS RESTRUCTURING PLAN WHICH REDUCED EMPLOYEE HEADCOUNT BY ABOUT 20% Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below